• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胞磷胆碱(Recognan)对各种疾病类型认知功能障碍矫正的疗效与安全性]

[Recognan (citicoline) efficacy and safety in cognitive impairment correction of various nosological forms].

作者信息

Shavlovskaya O A, Bokova I A

机构信息

International Restorative Medicine University, Moscow, Russia.

Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

出版信息

Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(11):22-28. doi: 10.17116/jnevro202312311122.

DOI:10.17116/jnevro202312311122
PMID:37994884
Abstract

Insufficiency of a choline derivative (acetylcholine) can lead to the development of cognitive impairment (CI). One of the most well-known and well-studied medical drugs (MD) containing choline and having neuroprotective properties is citicoline (Recognan). A number of studies have demonstrated the effectiveness of Recognan in relation to mild CI, chronic cerebrovascular diseases (CVD), acute vascular disorders (including post-traumatic genesis). Recognan improves memory and other cognitive functions in healthy young people against the background of asthenia due to stress or increased cognitive and emotional stress or infection, and also has a preventive effect on fading cognitive functions in the process of age-related changes. The duration of neuroprotection can reach 6 months or more - up to 12 months, depending on the patient's condition. Therapy regimens include two-stage Recognan prescribing: with CVD intramuscularly (i/m) at 1000 mg /d for 30 days, in the acute period of ischemic stroke, i/m or intravenously (i/v) at 1000 mg every 12 hours from the first day after diagnosis, 3-5 days after the start of therapy, with preservation functions of swallowing, it is possible to switch to per oral (p/o) drug administration.

摘要

胆碱衍生物(乙酰胆碱)不足会导致认知障碍(CI)的发生。含有胆碱且具有神经保护特性的最知名且研究充分的药物之一是胞磷胆碱(可益能)。多项研究已证明可益能在治疗轻度CI、慢性脑血管疾病(CVD)、急性血管疾病(包括创伤后病因)方面的有效性。可益能可改善健康年轻人在因压力、认知和情绪压力增加或感染导致的虚弱状态下的记忆力及其他认知功能,并且对与年龄相关变化过程中逐渐衰退的认知功能具有预防作用。神经保护作用的持续时间可达6个月或更长——长达12个月,具体取决于患者病情。治疗方案包括两阶段使用可益能:对于CVD,肌肉注射(i/m),每日1000毫克,持续30天;在缺血性中风急性期,从诊断后的第一天起,每12小时肌肉注射或静脉注射(i/v)1000毫克,治疗开始3 - 5天后,若吞咽功能尚存,可改为口服(p/o)给药。

相似文献

1
[Recognan (citicoline) efficacy and safety in cognitive impairment correction of various nosological forms].[胞磷胆碱(Recognan)对各种疾病类型认知功能障碍矫正的疗效与安全性]
Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(11):22-28. doi: 10.17116/jnevro202312311122.
2
[Multicenter observational program for evaluation of the effectiveness of the recognan (citicoline) in the correction of cognitive impairment in patients with chronic cerebrovascular pathology].[多中心观察项目:评估可尼丁(胞磷胆碱)对慢性脑血管病变患者认知障碍的纠正效果]
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(8):39-43. doi: 10.17116/jnevro20171178139-43.
3
[Asthenic disorders correction with Recognan].使用Recognan纠正虚弱症
Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(3):57-62. doi: 10.17116/jnevro202412403157.
4
[The effect of the use of the drug recognan (citicoline) on the state of higher mental functions in patients with mild cognitive impairment].[药物瑞可安(胞磷胆碱)对轻度认知障碍患者高级心理功能状态的影响]
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(9):51-57. doi: 10.17116/jnevro202112109151.
5
[Current treatment options for autonomic, cognitive and emotional disorders in patients with asthenic syndrome treated with recognan (citicoline)].[使用瑞可南(胞磷胆碱)治疗虚弱综合征患者自主神经、认知和情感障碍的当前治疗选择]
Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(7):27-34. doi: 10.17116/jnevro201911907127.
6
[The influence of the drug recognan (citicoline) on neurodynamic characteristics of mental activity in patients with mild cognitive impairment].[药物Recognan(胞磷胆碱)对轻度认知障碍患者精神活动神经动力学特征的影响]
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(1):43-46. doi: 10.17116/jnevro202112101143.
7
[The efficacy of recognan in the early stage of ischemic stroke].[瑞格纳(Recognan)在缺血性中风早期的疗效]
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):44-48. doi: 10.17116/jnevro201711710144-48.
8
[A multicenter observation study of the efficacy of cortexin and recognan (citicoline) in the treatment of cognitive impairments in chronic cerebrovascular pathology].[多中心观察性研究:皮质素与胞磷胆碱(可尼丁)治疗慢性脑血管病所致认知障碍的疗效]
Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2):35-38. doi: 10.17116/jnevro201911902135.
9
[Features of positive personality phenomena in patients with mild cognitive impairment and asthenic syndrome treated with recognan (citicoline)].[使用雷卡南(胞磷胆碱)治疗的轻度认知障碍和虚弱综合征患者的积极人格现象特征]
Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(1):44-50. doi: 10.17116/jnevro202012001144.
10
[Recognan (citicoline) in the correction of asthenic and anxiety-depressive disorders].[胞磷胆碱(可尼可)对虚弱及焦虑抑郁障碍的纠正作用]
Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(6):43-47. doi: 10.17116/jnevro202412406143.